Bilateral Vestibular Schwannomas in Neurofibromatosis Type 2

被引：5
|
作者：
Meola, Antonio [1 ]
Chang, Steven D. [2 ]
机构：
[1] Stanford Hosp & Clin, Stanford, CA 94305 USA
[2] Stanford Univ, Stanford, CA 94305 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2018年 / 379卷 / 15期
关键词：
D O I：
10.1056/NEJMicm1804944
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1463 / 1463
页数：1
相关论文
共 50 条
  • [21] Conservative Management of Bilateral Vestibular Schwannomas in Neurofibromatosis Type 2 Patients: Hearing and Tumor Growth Results COMMENTS
    Schwartz, Marc S.
    Link, Michael J.
    NEUROSURGERY, 2013, 72 (06) : 914 - 914
  • [22] Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2
    Stivaros, Stavros M.
    Stemmer-Rachamimov, Anat O.
    Alston, Robert
    Plotkin, Scott R.
    Nadol, Joseph B.
    Quesnel, Alicia
    O'Malley, Jennifer
    Whitfield, Gillian A.
    McCabe, Martin G.
    Freeman, Simon R.
    Lloyd, Simon K.
    Wright, Neville B.
    Kilday, John-Paul
    Kamaly-Asl, Ian D.
    Mills, Samantha J.
    Rutherford, Scott A.
    King, Andrew T.
    Evans, D. Gareth
    JOURNAL OF MEDICAL GENETICS, 2015, 52 (08) : 557 - 562
  • [23] Early proactive management of vestibular schwannomas in neurofibromatosis type 2 - Comments
    Pollock, BE
    NEUROSURGERY, 2001, 49 (02) : 281 - 282
  • [24] Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis Type 2 - Comments
    Chen, Joseph C. T.
    Chang, Steven D.
    Sheehan, Jason P.
    Kondziolka, Douglas
    NEUROSURGERY, 2008, 62 (05) : A42 - A43
  • [25] Long-term clinical outcomes of stereotactic radiotherapy for bilateral vestibular schwannomas in neurofibromatosis type 2 patients
    Puataweepong, Putipun
    Dhanacha, Mantana
    Ruangkanchanasetr, Rawee
    Boonyawan, Keeratikarn
    Hansasuta, Ake
    Saetia, Kriangsak
    Yongvithisatid, Pornpan
    JOURNAL OF NEURO-ONCOLOGY, 2023, 164 (03) : 587 - 595
  • [26] BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS TYPE 2 AND SYMPTOMATIC VESTIBULAR SCHWANNOMAS
    Blakeley, Jaishri
    Ye, Xiaobu
    Bergner, Amanda
    Dombi, Eva
    Zalewski, Christopher
    Follmer, Krista
    Halpin, Chris
    Fayad, Laura
    Jacobs, Michael
    Baldwin, Andrea
    Langmead, Shannon
    Whitcomb, Trish
    Jennings, Dominique
    Widemann, Brigitte
    Plotkin, Scott
    NEURO-ONCOLOGY, 2013, 15 : 101 - 101
  • [27] Long-term clinical outcomes of stereotactic radiotherapy for bilateral vestibular schwannomas in neurofibromatosis type 2 patients
    Putipun Puataweepong
    Mantana Dhanacha
    Rawee Ruangkanchanasetr
    Keeratikarn Boonyawan
    Ake Hansasuta
    Kriangsak Saetia
    Pornpan Yongvithisatid
    Journal of Neuro-Oncology, 2023, 164 : 587 - 595
  • [28] Reduced dosage of bevacizumab in treatment of vestibular schwannomas in patients with neurofibromatosis type 2
    Said Farschtschi
    Philipp Kollmann
    Carsten Dalchow
    Alexander Stein
    Victor-Felix Mautner
    European Archives of Oto-Rhino-Laryngology, 2015, 272 : 3857 - 3860
  • [29] Reduced dosage of bevacizumab in treatment of vestibular schwannomas in patients with neurofibromatosis type 2
    Farschtschi, Said
    Kollmann, Philipp
    Dalchow, Carsten
    Stein, Alexander
    Mautner, Victor-Felix
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2015, 272 (12) : 3857 - 3860
  • [30] Lack of Neurofibromatosis Type 2 Gene Promoter Methylation in Sporadic Vestibular Schwannomas
    Koutsimpelas, D.
    Ruerup, G.
    Mann, W. J.
    Brieger, J.
    ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY, 2012, 74 (01): : 33 - 37
12345